HEADER TRANSFERASE 30-JUN-21 7F7W TITLE JAK2-JH2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PSEUDOKINASE DOMAIN; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS JAK2, JH2, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.NIU REVDAT 2 29-NOV-23 7F7W 1 REMARK REVDAT 1 30-MAR-22 7F7W 0 JRNL AUTH M.HU,T.YANG,L.YANG,L.NIU,J.ZHU,A.ZHAO,M.SHI,X.YUAN,M.TANG, JRNL AUTH 2 J.YANG,H.PEI,Z.YANG,Q.CHEN,H.YE,T.NIU,L.CHEN JRNL TITL PRECLINICAL STUDIES OF FLONOLTINIB MALEATE, A NOVEL JRNL TITL 2 JAK2/FLT3 INHIBITOR, IN TREATMENT OF JAK2 V617F -INDUCED JRNL TITL 3 MYELOPROLIFERATIVE NEOPLASMS. JRNL REF BLOOD CANCER J V. 12 37 2022 JRNL REFN ISSN 2044-5385 JRNL PMID 35256594 JRNL DOI 10.1038/S41408-022-00628-2 REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 48992 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.460 REMARK 3 FREE R VALUE TEST SET COUNT : 1203 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 57.5400 - 3.8064 0.98 5449 138 0.1718 0.1823 REMARK 3 2 3.8064 - 3.0213 0.98 5380 137 0.1968 0.2381 REMARK 3 3 3.0213 - 2.6394 0.99 5389 131 0.2221 0.2676 REMARK 3 4 2.6394 - 2.3980 0.98 5315 133 0.2229 0.2687 REMARK 3 5 2.3980 - 2.2262 0.98 5312 140 0.2172 0.2703 REMARK 3 6 2.2262 - 2.0949 0.98 5280 131 0.2212 0.2636 REMARK 3 7 2.0949 - 1.9900 0.98 5298 134 0.2453 0.2942 REMARK 3 8 1.9900 - 1.9033 0.97 5244 134 0.2753 0.3392 REMARK 3 9 1.9033 - 1.8301 0.95 5122 125 0.3092 0.3572 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4638 REMARK 3 ANGLE : 1.000 6275 REMARK 3 CHIRALITY : 0.038 678 REMARK 3 PLANARITY : 0.005 802 REMARK 3 DIHEDRAL : 17.510 1733 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7F7W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300023043. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.988 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48992 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 58.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5UT5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, REMARK 280 12-20% PEG 4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.88500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD22 ASN A 548 O HOH A 1102 1.46 REMARK 500 HE ARG A 769 O HOH A 1103 1.50 REMARK 500 O HOH A 1199 O HOH B 1129 1.80 REMARK 500 O HOH B 1105 O HOH B 1176 1.89 REMARK 500 O HOH B 1101 O HOH B 1138 1.93 REMARK 500 O HOH B 1177 O HOH B 1194 1.95 REMARK 500 O HOH A 1212 O HOH A 1231 1.97 REMARK 500 O HOH A 1138 O HOH A 1142 2.00 REMARK 500 OD1 ASP B 544 NH2 ARG B 565 2.05 REMARK 500 O HOH A 1118 O HOH A 1187 2.06 REMARK 500 OE2 GLU A 767 O HOH A 1101 2.07 REMARK 500 OE1 GLU B 685 O HOH B 1101 2.07 REMARK 500 ND2 ASN A 548 O HOH A 1102 2.10 REMARK 500 O HOH A 1225 O HOH A 1230 2.15 REMARK 500 OG SER B 698 O HOH B 1102 2.16 REMARK 500 O ALA B 777 O HOH B 1103 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 548 -140.44 -115.01 REMARK 500 CYS A 618 126.44 -35.60 REMARK 500 ASN A 673 56.61 -154.20 REMARK 500 PHE A 809 -166.97 168.68 REMARK 500 ASN B 548 -142.40 -116.42 REMARK 500 CYS B 618 94.68 -36.92 REMARK 500 ASN B 673 57.58 -152.22 REMARK 500 THR B 689 -18.38 72.27 REMARK 500 PHE B 809 -178.83 -170.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1205 DISTANCE = 6.86 ANGSTROMS DBREF 7F7W A 536 810 UNP O60674 JAK2_HUMAN 536 810 DBREF 7F7W B 536 810 UNP O60674 JAK2_HUMAN 536 810 SEQADV 7F7W PHE A 617 UNP O60674 VAL 617 VARIANT SEQADV 7F7W ALA A 777 UNP O60674 TRP 777 CONFLICT SEQADV 7F7W HIS A 794 UNP O60674 PHE 794 CONFLICT SEQADV 7F7W PHE B 617 UNP O60674 VAL 617 VARIANT SEQADV 7F7W ALA B 777 UNP O60674 TRP 777 CONFLICT SEQADV 7F7W HIS B 794 UNP O60674 PHE 794 CONFLICT SEQRES 1 A 275 VAL PHE HIS LYS ILE ARG ASN GLU ASP LEU ILE PHE ASN SEQRES 2 A 275 GLU SER LEU GLY GLN GLY THR PHE THR LYS ILE PHE LYS SEQRES 3 A 275 GLY VAL ARG ARG GLU VAL GLY ASP TYR GLY GLN LEU HIS SEQRES 4 A 275 GLU THR GLU VAL LEU LEU LYS VAL LEU ASP LYS ALA HIS SEQRES 5 A 275 ARG ASN TYR SER GLU SER PHE PHE GLU ALA ALA SER MET SEQRES 6 A 275 MET SER LYS LEU SER HIS LYS HIS LEU VAL LEU ASN TYR SEQRES 7 A 275 GLY VAL CYS PHE CYS GLY ASP GLU ASN ILE LEU VAL GLN SEQRES 8 A 275 GLU PHE VAL LYS PHE GLY SER LEU ASP THR TYR LEU LYS SEQRES 9 A 275 LYS ASN LYS ASN CYS ILE ASN ILE LEU TRP LYS LEU GLU SEQRES 10 A 275 VAL ALA LYS GLN LEU ALA TRP ALA MET HIS PHE LEU GLU SEQRES 11 A 275 GLU ASN THR LEU ILE HIS GLY ASN VAL CYS ALA LYS ASN SEQRES 12 A 275 ILE LEU LEU ILE ARG GLU GLU ASP ARG LYS THR GLY ASN SEQRES 13 A 275 PRO PRO PHE ILE LYS LEU SER ASP PRO GLY ILE SER ILE SEQRES 14 A 275 THR VAL LEU PRO LYS ASP ILE LEU GLN GLU ARG ILE PRO SEQRES 15 A 275 TRP VAL PRO PRO GLU CYS ILE GLU ASN PRO LYS ASN LEU SEQRES 16 A 275 ASN LEU ALA THR ASP LYS TRP SER PHE GLY THR THR LEU SEQRES 17 A 275 TRP GLU ILE CYS SER GLY GLY ASP LYS PRO LEU SER ALA SEQRES 18 A 275 LEU ASP SER GLN ARG LYS LEU GLN PHE TYR GLU ASP ARG SEQRES 19 A 275 HIS GLN LEU PRO ALA PRO LYS ALA ALA GLU LEU ALA ASN SEQRES 20 A 275 LEU ILE ASN ASN CYS MET ASP TYR GLU PRO ASP HIS ARG SEQRES 21 A 275 PRO SER PHE ARG ALA ILE ILE ARG ASP LEU ASN SER LEU SEQRES 22 A 275 PHE THR SEQRES 1 B 275 VAL PHE HIS LYS ILE ARG ASN GLU ASP LEU ILE PHE ASN SEQRES 2 B 275 GLU SER LEU GLY GLN GLY THR PHE THR LYS ILE PHE LYS SEQRES 3 B 275 GLY VAL ARG ARG GLU VAL GLY ASP TYR GLY GLN LEU HIS SEQRES 4 B 275 GLU THR GLU VAL LEU LEU LYS VAL LEU ASP LYS ALA HIS SEQRES 5 B 275 ARG ASN TYR SER GLU SER PHE PHE GLU ALA ALA SER MET SEQRES 6 B 275 MET SER LYS LEU SER HIS LYS HIS LEU VAL LEU ASN TYR SEQRES 7 B 275 GLY VAL CYS PHE CYS GLY ASP GLU ASN ILE LEU VAL GLN SEQRES 8 B 275 GLU PHE VAL LYS PHE GLY SER LEU ASP THR TYR LEU LYS SEQRES 9 B 275 LYS ASN LYS ASN CYS ILE ASN ILE LEU TRP LYS LEU GLU SEQRES 10 B 275 VAL ALA LYS GLN LEU ALA TRP ALA MET HIS PHE LEU GLU SEQRES 11 B 275 GLU ASN THR LEU ILE HIS GLY ASN VAL CYS ALA LYS ASN SEQRES 12 B 275 ILE LEU LEU ILE ARG GLU GLU ASP ARG LYS THR GLY ASN SEQRES 13 B 275 PRO PRO PHE ILE LYS LEU SER ASP PRO GLY ILE SER ILE SEQRES 14 B 275 THR VAL LEU PRO LYS ASP ILE LEU GLN GLU ARG ILE PRO SEQRES 15 B 275 TRP VAL PRO PRO GLU CYS ILE GLU ASN PRO LYS ASN LEU SEQRES 16 B 275 ASN LEU ALA THR ASP LYS TRP SER PHE GLY THR THR LEU SEQRES 17 B 275 TRP GLU ILE CYS SER GLY GLY ASP LYS PRO LEU SER ALA SEQRES 18 B 275 LEU ASP SER GLN ARG LYS LEU GLN PHE TYR GLU ASP ARG SEQRES 19 B 275 HIS GLN LEU PRO ALA PRO LYS ALA ALA GLU LEU ALA ASN SEQRES 20 B 275 LEU ILE ASN ASN CYS MET ASP TYR GLU PRO ASP HIS ARG SEQRES 21 B 275 PRO SER PHE ARG ALA ILE ILE ARG ASP LEU ASN SER LEU SEQRES 22 B 275 PHE THR HET 36H A1000 68 HET 36H B1000 68 HETNAM 36H 2-((1-(2-FLUORO-4-((4-(1-ISOPROPYL-1H-PYRAZOL-4-YL)-5- HETNAM 2 36H METHYLPYRIMIDIN-2-YL)AMINO)PHENYL)PIPERIDIN-4-YL) HETNAM 3 36H (METHYL)AMINO)ETHAN-1-OL FORMUL 3 36H 2(C25 H34 F N7 O) FORMUL 5 HOH *237(H2 O) HELIX 1 AA1 ARG A 541 GLU A 543 5 3 HELIX 2 AA2 ASP A 569 GLY A 571 5 3 HELIX 3 AA3 LYS A 585 ASN A 589 5 5 HELIX 4 AA4 TYR A 590 LYS A 603 1 14 HELIX 5 AA5 SER A 633 ASN A 641 1 9 HELIX 6 AA6 ASN A 646 ASN A 667 1 22 HELIX 7 AA7 CYS A 675 LYS A 677 5 3 HELIX 8 AA8 PRO A 708 ARG A 715 1 8 HELIX 9 AA9 PRO A 720 ASN A 726 1 7 HELIX 10 AB1 PRO A 727 LEU A 730 5 4 HELIX 11 AB2 ASN A 731 SER A 748 1 18 HELIX 12 AB3 ASP A 758 ASP A 768 1 11 HELIX 13 AB4 ALA A 777 GLU A 779 5 3 HELIX 14 AB5 LEU A 780 MET A 788 1 9 HELIX 15 AB6 GLU A 791 ARG A 795 5 5 HELIX 16 AB7 SER A 797 SER A 807 1 11 HELIX 17 AB8 ARG B 541 GLU B 543 5 3 HELIX 18 AB9 ASP B 569 GLY B 571 5 3 HELIX 19 AC1 HIS B 587 ASN B 589 5 3 HELIX 20 AC2 TYR B 590 LYS B 603 1 14 HELIX 21 AC3 SER B 633 ASN B 641 1 9 HELIX 22 AC4 ASN B 646 ASN B 667 1 22 HELIX 23 AC5 CYS B 675 LYS B 677 5 3 HELIX 24 AC6 PRO B 708 ARG B 715 1 8 HELIX 25 AC7 PRO B 720 ASN B 726 1 7 HELIX 26 AC8 PRO B 727 LEU B 730 5 4 HELIX 27 AC9 ASN B 731 SER B 748 1 18 HELIX 28 AD1 ASP B 758 ASP B 768 1 11 HELIX 29 AD2 LEU B 780 MET B 788 1 9 HELIX 30 AD3 GLU B 791 ARG B 795 5 5 HELIX 31 AD4 SER B 797 SER B 807 1 11 SHEET 1 AA1 5 LEU A 545 GLY A 554 0 SHEET 2 AA1 5 THR A 557 VAL A 567 -1 O ILE A 559 N LEU A 551 SHEET 3 AA1 5 LEU A 573 LEU A 583 -1 O THR A 576 N ARG A 564 SHEET 4 AA1 5 ILE A 623 GLU A 627 -1 O GLN A 626 N LEU A 579 SHEET 5 AA1 5 ASN A 612 CYS A 616 -1 N GLY A 614 O VAL A 625 SHEET 1 AA2 2 ILE A 679 ARG A 683 0 SHEET 2 AA2 2 PHE A 694 LEU A 697 -1 O LYS A 696 N LEU A 680 SHEET 1 AA3 5 LEU B 545 GLY B 554 0 SHEET 2 AA3 5 THR B 557 VAL B 567 -1 O ILE B 559 N LEU B 551 SHEET 3 AA3 5 LEU B 573 LEU B 583 -1 O HIS B 574 N GLU B 566 SHEET 4 AA3 5 ILE B 623 GLU B 627 -1 O GLN B 626 N LEU B 579 SHEET 5 AA3 5 ASN B 612 CYS B 616 -1 N GLY B 614 O VAL B 625 SHEET 1 AA4 2 ILE B 679 ARG B 683 0 SHEET 2 AA4 2 PHE B 694 LEU B 697 -1 O LYS B 696 N LEU B 680 SSBOND 1 CYS A 616 CYS A 618 1555 1555 2.05 SSBOND 2 CYS B 616 CYS B 618 1555 1555 2.03 CISPEP 1 ILE A 716 PRO A 717 0 6.19 CISPEP 2 ILE B 716 PRO B 717 0 5.68 CRYST1 60.980 57.770 86.240 90.00 109.32 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016399 0.000000 0.005749 0.00000 SCALE2 0.000000 0.017310 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012288 0.00000